NOHRA GUY P 4

What Happened Guy P. Nohra, a director of TELA Bio, was granted a total of 58,485 equity awards on June 9, 2026. The awards break down as 23,600 restricted stock units (11,925 and 11,675 RSUs) and 34,885 derivative awards (17,550 and 17,335 option-type awards). All grants were reported with an acquisition price of $0.00 (award grants), i.e., no cash paid by the reporting person.

Key Details

• Transaction date: June 9, 2026; Form 4 filed June 11, 2026 (timely filing within the usual 2-business-day window).
• Price: $0.00 for all four grant items (transaction code A = award/grant).
• Totals: 23,600 RSUs + 34,885 option-type awards = 58,485 shares underlying awards.
• Vesting highlights from filing footnotes:
  • One RSU grant vests in three equal annual installments beginning June 9, 2027 (F1).
  • The other RSU grant vests on the earlier of June 9, 2027, the next annual meeting, or a Change in Control (F2).
  • One option-type award vests in 36 equal monthly installments starting June 9, 2026 (F3).
  • The other option-type award vests on the earlier of June 9, 2027, the next annual meeting, or a Change in Control (F4).
• Shares owned after the transaction: not specified in the reported transaction details.
• No 10b5-1 plan, tax-withholding sale, or exercise/sale was disclosed in this filing.

Context These are compensation grants to a director (common for board service) rather than open-market purchases or sales. The derivative awards are not exercises — they are grants that will vest according to the schedules above before the director can realize value. Awards granted at $0.00 are typical for equity compensation and do not by themselves indicate the director bought or sold stock.